[ Back to EurekAlert! ]

Contact: Laura Gerding
gerdingla@health.missouri.edu
573-882-9193
University of Missouri School of Medicine

Stefan Sarafianos, University of Missouri School of Medicine

Caption: With a new $3.4 million grant from the National Institutes of Health, scientist Stefan Sarafianos, Ph.D., MU Chancellor's Chair for Excellence in Molecular Virology, is developing new compounds that target an enzyme in HIV that has escaped the reach of existing drugs.

Credit: University of Missouri School of Medicine

Usage Restrictions: None

Related news release: Researchers attack HIV's final defenses before drug-resistant mutations emerge


[ Back to EurekAlert! ]